UK markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2949+0.0199 (+7.24%)
At close: 04:00PM EDT
0.3135 +0.02 (+6.31%)
After hours: 07:57PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-6,076
-7,948
-18,600
-10,203
-8,939
Depreciation & amortisation
603.629
595.997
511.787
228.694
112.429
Stock-based compensation
139.24
278.155
697.894
610.193
994.401
Change in working capital
-1,298
-565.821
-3,073
-450.45
358.105
Accounts receivable
-59.072
-219.147
-40.008
40.198
17.273
Inventory
140.41
565.561
-2,004
0
-
Other working capital
-6,658
-7,445
-15,623
-9,792
-7,417
Other non-cash items
-1.682
-0.803
1,394
266.53
17.294
Net cash provided by operating activities
-6,615
-7,283
-15,584
-9,791
-7,375
Cash flows from investing activities
Investments in property, plant and equipment
-42.899
-161.804
-39.108
-1.725
-42.573
Acquisitions, net
0
-500
-300.457
0
-
Purchases of investments
-84.781
-42.268
0
0
-43.619
Sales/maturities of investments
84.781
42.268
0
0
3,876
Other investing activities
-
-
-425
-
-
Net cash used for investing activities
-42.899
-661.804
-672.999
-1.725
3,791
Cash flows from financing activities
Debt repayment
-
0
-290.826
0
-71.2952
Common stock issued
5,974
12,000
17,146
12,473
0
Other financing activities
-
-1,320
-1,785
-1,618
-30.993
Net cash used provided by (used for) financing activities
4,654
10,681
15,070
10,855
-30.993
Net change in cash
-2,003
2,736
-1,186
1,557
-4,031
Cash at beginning of period
9,604
6,177
7,363
5,806
9,837
Cash at end of period
7,601
8,913
6,177
7,363
5,806
Free cash flow
Operating cash flow
-6,615
-7,283
-15,584
-9,791
-7,375
Capital expenditure
-42.899
-161.804
-39.108
-1.725
-42.573
Free cash flow
-6,658
-7,445
-15,623
-9,792
-7,417